An Occurrence of Eosinophilic Folliculitis and Alopecia Associated with a Sustained Complete Response to Mogamulizumab in Sézary Syndrome: A Case Report
January 2024
in “
Therapeutic Advances in Hematology
”
Studysummary This report suggests an association between eosinophilic folliculitis and sustained complete response in a Sézary syndrome patient treated with mogamulizumab, although regular monitoring is necessary to prevent relapse.
Automatically generated from the study's abstract, not written by a person, and not a review of the full paper. Not medical advice or a treatment recommendation. Read the original study, and consult a qualified healthcare professional before changing treatment. Full disclaimer
Read the full study on journals.sagepub.com →